Top Markets
Coin of the day
Chongqing Lummy Pharmaceutical Co., Ltd. Chongqing Lummy Pharmaceutical Co., Ltd.

Chongqing Lummy Pharmaceutical Co., Ltd.

300006
Rank in Stocks #10090
Chongqing Lummy Pharmaceutical Co., Ltd. is a Chinese firm dedicated to the... Chongqing Lummy Pharmaceutical Co., Ltd. is a Chinese firm dedicated to the research, development, production, and distribution of a broad spectrum of pharmaceutical products. Its extensive portfolio encompasses treatments for various therapeutic areas, including oncology, infectious diseases (antibacterial, antiviral, and antifungal), liver support, and endocrine disorders. The company also develops and markets medications for the digestive, immune, blood, cardiovascular, and nervous systems, in addition to traditional Chinese patent medicines. Further offerings include electrolyte and acid-base balancing agents, nutritional supplements, large volume parenteral solutions, American ginseng preparations, and active pharmaceutical ingredients. Established in 1999, the company's headquarters are located in Chongqing, China.
Share Price
$0.84484795
Last synced: 2026-08-28
Market Cap
$892.08M
Change (1 day)
-4.11%
Change (1 year)
27.37%
Country
CN
Trade Chongqing Lummy Pharmaceutical Co., Ltd. (300006)

Category

P/E ratio for Chongqing Lummy Pharmaceutical Co., Ltd. (300006)
P/E ratio as of 2026 TTM: 0
According to Chongqing Lummy Pharmaceutical Co., Ltd. latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2026 the company had a P/E ratio of 0.
P/E ratio history for Chongqing Lummy Pharmaceutical Co., Ltd. from 2026 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
Not enough data for the provided dates.
P/E ratio for similar companies or competitors
Company P/E Ratio P/E Ratio Difference Country
39.54 -
US
30.10 -
US
70.28 -
US
22.25 -
CH
107.81 -
US
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.